anonymous
Guest
anonymous
Guest
Pretty soon the "worst sales force" in Pharma (Shire Reps) will be reduced by 35%.NBU OBU is GONE !
We are only keeping the most talented, hard-working select group of high ranked colleagues who are focused on supporting patients. We only want those who are excited about being part of a company, that is making a major impact on the rare disease community.
And.....how the hell do you plan to pay for all the rare disease research and costs? NBU and OBU have the products that will pay for the rest of the company to function. What will Shire do if the money makers are gone? Money doesn’t just fall from the sky.......